Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cheol-In Kang

Showing results (141-150 of 275) with videos related to

Pageof 28
Sort By:
Journal of Korean Medical Science|September 19, 2023
Clinical Utility of Sero-Immunological Responses Against SARS-CoV-2 Nucleocapsid Protein During Subsequent Prevalence of Wild-Type, Delta Variant, and Omicron VariantBeomki Lee, Jae-Hoon Ko, Jin Yang Baek, et al.
The Journal of Antimicrobial Chemotherapy|January 31, 2008
Clinical implications of vancomycin-resistant Enterococcus faecium (VRE) with VanD phenotype and vanA genotypeJae-Hoon Song, Kwan Soo Ko, Ji Yoeun Suh, et al.
Diagnostic Microbiology and Infectious Disease|December 4, 2015
Comparison of the microbiological characteristics and virulence factors of ST131 and non-ST131 clones among extended-spectrum β-lactamase-producing Escherichia coli causing bacteremiaMin Kyeong Cha, Cheol-In Kang, So Hyun Kim, et al.
Journal of Global Antimicrobial Resistance|September 25, 2017
Resistance mechanisms and clinical characteristics of linezolid-resistant Enterococcus faecium isolates: A single-centre study in South KoreaSun Young Cho, Hye Mee Kim, Doo Ryeon Chung, et al.
Microbial Drug Resistance (Larchmont, N.Y.)|March 11, 2015
Clinical Features and Treatment Outcomes of Bloodstream Infections Caused by Extended-Spectrum β-Lactamase-Producing Escherichia coli Sequence Type 131Sun Young Cho, Cheol-In Kang, Min Kyeong Cha, et al.
Antimicrobial Agents and Chemotherapy|July 1, 2015
In vitro activities of 21 antimicrobial agents alone and in combination with aminoglycosides or fluoroquinolones against extended-spectrum-β-lactamase-producing Escherichia coli isolates causing bacteremiaMin Kyeong Cha, Cheol-In Kang, So Hyun Kim, et al.
Emerging Infectious Diseases|April 23, 2014
Extensively drug-resistant Streptococcus pneumoniae, South Korea, 2011-2012Sun Young Cho, Jin Yang Baek, Cheol-In Kang, et al.
The Journal of Antimicrobial Chemotherapy|July 16, 2004
Outcome of inappropriate initial antimicrobial treatment in patients with methicillin-resistant Staphylococcus aureus bacteraemiaSung-Han Kim, Wan-Beom Park, Ki-Deok Lee, et al.
Infection Control and Hospital Epidemiology|November 3, 2004
Risk factors for and clinical outcomes of bloodstream infections caused by extended-spectrum beta-lactamase-producing Klebsiella pneumoniaeCheol-In Kang, Sung-Han Kim, Dong Min Kim, et al.
Journal of Korean Medical Science|December 29, 2007
Tuberculosis among dislocated North Koreans entering Republic of Korea since 1999Chang Min Choi, Jung Hee June, Cheol In Kang, et al.
Pageof 28

Showing results (141-150 of 275) with videos related to

Sort By:
Pageof 28
Journal of Korean Medical Science|September 19, 2023
Clinical Utility of Sero-Immunological Responses Against SARS-CoV-2 Nucleocapsid Protein During Subsequent Prevalence of Wild-Type, Delta Variant, and Omicron VariantBeomki Lee, Jae-Hoon Ko, Jin Yang Baek, et al.
The Journal of Antimicrobial Chemotherapy|January 31, 2008
Clinical implications of vancomycin-resistant Enterococcus faecium (VRE) with VanD phenotype and vanA genotypeJae-Hoon Song, Kwan Soo Ko, Ji Yoeun Suh, et al.
Diagnostic Microbiology and Infectious Disease|December 4, 2015
Comparison of the microbiological characteristics and virulence factors of ST131 and non-ST131 clones among extended-spectrum β-lactamase-producing Escherichia coli causing bacteremiaMin Kyeong Cha, Cheol-In Kang, So Hyun Kim, et al.
Journal of Global Antimicrobial Resistance|September 25, 2017
Resistance mechanisms and clinical characteristics of linezolid-resistant Enterococcus faecium isolates: A single-centre study in South KoreaSun Young Cho, Hye Mee Kim, Doo Ryeon Chung, et al.
Microbial Drug Resistance (Larchmont, N.Y.)|March 11, 2015
Clinical Features and Treatment Outcomes of Bloodstream Infections Caused by Extended-Spectrum β-Lactamase-Producing Escherichia coli Sequence Type 131Sun Young Cho, Cheol-In Kang, Min Kyeong Cha, et al.
Antimicrobial Agents and Chemotherapy|July 1, 2015
In vitro activities of 21 antimicrobial agents alone and in combination with aminoglycosides or fluoroquinolones against extended-spectrum-β-lactamase-producing Escherichia coli isolates causing bacteremiaMin Kyeong Cha, Cheol-In Kang, So Hyun Kim, et al.
Emerging Infectious Diseases|April 23, 2014
Extensively drug-resistant Streptococcus pneumoniae, South Korea, 2011-2012Sun Young Cho, Jin Yang Baek, Cheol-In Kang, et al.
The Journal of Antimicrobial Chemotherapy|July 16, 2004
Outcome of inappropriate initial antimicrobial treatment in patients with methicillin-resistant Staphylococcus aureus bacteraemiaSung-Han Kim, Wan-Beom Park, Ki-Deok Lee, et al.
Infection Control and Hospital Epidemiology|November 3, 2004
Risk factors for and clinical outcomes of bloodstream infections caused by extended-spectrum beta-lactamase-producing Klebsiella pneumoniaeCheol-In Kang, Sung-Han Kim, Dong Min Kim, et al.
Journal of Korean Medical Science|December 29, 2007
Tuberculosis among dislocated North Koreans entering Republic of Korea since 1999Chang Min Choi, Jung Hee June, Cheol In Kang, et al.
Pageof 28